CytomX Therapeutics, Inc. — 8-K Filings
126 8-K filings on record
This page lists all 8-K filings submitted to the SEC by CytomX Therapeutics, Inc. (CTMX), sorted by most recent first. Each row links to the full filing on EdgarLookup. CytomX Therapeutics, Inc. has filed 126 8-K documents with the SEC since 2010. To view all SEC filings by CytomX Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K-050621 Q1-21 EARNINGS | 0001564590-21-024964 | May 6, 2021 | — |
| 8-K | 8-K | 0001193125-21-069514 | Mar 4, 2021 | Feb 26, 2021 |
| 8-K | 8-K - YE 2020 EARNINGS | 0001564590-21-008088 | Feb 24, 2021 | — |
| 8-K | 8-K | 0001193125-21-016452 | Jan 25, 2021 | Jan 20, 2021 |
| 8-K | 8-K | 0001193125-21-011589 | Jan 19, 2021 | — |
| 8-K | 8-K | 0001193125-20-324542 | Dec 22, 2020 | Dec 16, 2020 |
| 8-K | 8-K - Q3-20 EARNINGS | 0001564590-20-051317 | Nov 5, 2020 | — |
| 8-K | 8-K | 0001193125-20-264740 | Oct 6, 2020 | — |
| 8-K | 8-K Q2-20 EARNINGS | 0001564590-20-037749 | Aug 6, 2020 | — |
| 8-K | 8-K | 0001193125-20-176532 | Jun 23, 2020 | Jun 17, 2020 |
| 8-K | 8-K | 0001193125-20-155943 | May 29, 2020 | — |
| 8-K | 8-K-EARNINGS Q1-20 | 0001564590-20-022870 | May 7, 2020 | — |
| 8-K | 8-K | 0001193125-20-123071 | Apr 28, 2020 | Apr 27, 2020 |
| 8-K | 8-K | 0001193125-20-090977 | Mar 30, 2020 | — |
| 8-K | 8-K | 0001193125-20-083210 | Mar 24, 2020 | Mar 23, 2020 |
| 8-K | 8-K | 0001193125-20-082679 | Mar 23, 2020 | — |
| 8-K | 8-K Q4 2019 EARNINGS | 0001564590-20-007430 | Feb 27, 2020 | — |
| 8-K | 8-K | 0001193125-20-043696 | Feb 20, 2020 | Feb 14, 2020 |
| 8-K | 2019-11-06 8-K Q3-2019 EARNINGS | 0001564590-19-041743 | Nov 7, 2019 | — |
| 8-K | 8-K | 0001193125-19-234035 | Aug 29, 2019 | Aug 28, 2019 |
| 8-K | FORM 8-K | 0001193125-19-226958 | Aug 22, 2019 | Aug 19, 2019 |
| 8-K | 8-K | 0001564590-19-030064 | Aug 7, 2019 | — |
| 8-K | FORM 8-K | 0001193125-19-178790 | Jun 21, 2019 | Jun 19, 2019 |
| 8-K | 8-K | 0001193125-19-158784 | May 29, 2019 | May 22, 2019 |
| 8-K | 8-K | 0001564590-19-017981 | May 9, 2019 | — |
| 8-K | FORM 8-K | 0001193125-19-113391 | Apr 22, 2019 | Apr 17, 2019 |
| 8-K | FORM 8-K | 0001193125-19-100706 | Apr 8, 2019 | Apr 2, 2019 |
| 8-K | 8-K | 0001193125-19-085264 | Mar 25, 2019 | Mar 20, 2019 |
| 8-K | 8-K | 0001564590-19-004900 | Feb 27, 2019 | — |
| 8-K | 8-K - R&D DAY | 0001564590-19-004252 | Feb 26, 2019 | — |
| 8-K | FORM 8-K | 0001193125-19-023949 | Jan 31, 2019 | Jan 25, 2019 |
| 8-K | 8-K | 0001193125-18-353898 | Dec 20, 2018 | Dec 19, 2018 |
| 8-K | 8-K FOR Q3 2018 EARNING RELEASE | 0001564590-18-027403 | Nov 6, 2018 | — |
| 8-K | 8-K | 0001564590-18-024564 | Oct 22, 2018 | — |
| 8-K | 8-K | 0001564590-18-020463 | Aug 8, 2018 | — |
| 8-K | 8-K | 0001193125-18-219686 | Jul 17, 2018 | Jul 12, 2018 |
| 8-K | FORM 8-K | 0001193125-18-215419 | Jul 10, 2018 | — |
| 8-K | 8-K | 0001564590-18-015683 | Jun 15, 2018 | Jun 13, 2018 |
| 8-K | 8-K | 0001193125-18-182602 | Jun 4, 2018 | — |
| 8-K | 8-K | 0001193125-18-170157 | May 22, 2018 | — |
| 8-K | 8-K | 0001564590-18-013786 | May 16, 2018 | — |
| 8-K | 8-K | 0001564590-18-012390 | May 9, 2018 | — |
| 8-K | 8-K | 0001564590-18-004745 | Mar 7, 2018 | — |
| 8-K | FORM 8-K | 0001193125-18-023882 | Jan 29, 2018 | Jan 24, 2018 |
| 8-K | FORM 8-K | 0001193125-18-005150 | Jan 8, 2018 | — |
| 8-K | 8-K | 0001564590-17-024501 | Dec 4, 2017 | Dec 1, 2017 |
| 8-K | 8-K | 0001564590-17-024265 | Nov 28, 2017 | — |
| 8-K | 8-K | 0001564590-17-022260 | Nov 7, 2017 | — |
| 8-K | 8-K | 0001564590-17-019886 | Oct 24, 2017 | Oct 23, 2017 |
| 8-K | 8-K | 0001193125-17-302235 | Oct 3, 2017 | Sep 29, 2017 |